Diadema Partners »

Larimar Therapeutics shares owned by Diadema Partners

Quarter-by-quarter ownership of Larimar Therapeutics (LRMR) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Larimar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Larimar Therapeutics held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Larimar Therapeutics by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $750k 167k 4.50

More positions owned by Diadema Partners

United Therapeutics Corporation Put Option (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Viking Therapeutics (VKTX)
Capricor Therapeutics Com New Call Option (CAPR)
Abivax Sa Sponsored Ads (ABVX)
Liquidia Corporation Com New Call Option (LQDA)
Revolution Medicines (RVMD)
Apogee Therapeutics Call Option (APGE)
Bridgebio Pharma Note 1.750% 3/0
Incyte Corporation Put Option (INCY)
Kodiak Sciences Put Option (KOD)
Cytokinetics Com New Call Option (CYTK)
Johnson & Johnson (JNJ)
Cogent Biosciences (COGT)
Merck & Co Put Option (MRK)

View all positions for Diadema Partners

Top funds holding Larimar Therapeutics

Deerfield Management Company
Blue Owl Capital Holdings
BlackRock
Millennium Management
AIGH Capital Management
Driehaus Capital Management
Vanguard Capital Management
DAFNA Capital Management
Goldman Sachs Group
Deep Track Capital
Rtw Investments
Woodline Partners
Geode Capital Management
Soleus Capital Management
Point72 Asset Management

View all funds holding Larimar Therapeutics